-
February 12-15: Introduction to Health Economics and Outcomes Research- Virtual
-
Patient WAIT Survey Findings Across 8 LATAM Countries
-
Measuring Value in Oncology: Are We Keeping Pace with Science?
-
March 13-14: Introduction to Modeling Methods- Virtual
-
March 27-28: Data Transportability in HTAs: An Introduction to Transportability Analysis for the Assessment of External Validity in RWE Studies- Virtual
-
Beyond the Boundaries of RCT Data: Connecting Trials to the Real-World
-
Measuring the Indirect Costs Driving Financial Toxicity in Oncology
-
April 10-11: Budget Impact Analysis I: A 6-Step Approach- Virtual
-
Revolutionizing Clinical Trials: Harnessing Real-World Evidence to Drive Diversity and Clinical Implementation
-
April 17-18: Learning and Applying Discrete Event Simulation- Virtual
-
May 5: A Health Economics Approach to US Value Assessment Frameworks- In Person at ISPOR 2024
-
May 5: Developing Decision-Grade Real-World Evidence- In Person at ISPOR 2024
-
May 5: Advanced Patient-Reported Outcomes- In Person at ISPOR 2024
-
May 5: Applied Cost-Effectiveness Modeling with R- In Person at ISPOR 2024
-
May 5: Introduction to Machine Learning Methods- In Person at ISPOR 2024
-
May 5: Introduction to Health Technology Assessment- In Person at ISPOR 2024
-
May 5: Estimating Health-State Utility for Economic Models in Clinical Trials and Real-World Studies- In Person at ISPOR 2024
-
May 5: Valuation of Innovative Drugs- In Person at ISPOR 2024
-
May 5: Handling Uncertainty in Health Technology Assessment Processes- In Person at ISPOR 2024
-
May 5: Network Meta-Analysis in Relative Effectiveness Research- In Person at ISPOR 2024